Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Underwriting Agreement
- 5.1 Consent of Andrew I. Telsey, P.C.
- 5.2 Opinion of Sichenzia Ross Ference Carmel LLP
- 10.19 Form of Warrant Agency Agreement for This Offering
- 10.20 Form of Pre-funded Warrant for This Offering
- 10.21 Form of Series a Warrant for This Offering
- 10.22 Form of Series B Warrant for This Offering
- 23.1 Consent
- Download Excel data file
- View Excel data file
Associated filings
- 12 Nov 24 424B4 Prospectus supplement with pricing info
- 12 Nov 24 EFFECT Notice of effectiveness
- 6 Nov 24 POS AM Prospectus update (post-effective amendment)
- 14 Feb 24 424B4 Prospectus supplement with pricing info
- 13 Feb 24 EFFECT Notice of effectiveness
-
9 Feb 24 S-1/A IPO registration (amended)
- 6 Feb 24 UPLOAD Letter from SEC
- 1 Feb 24 S-1 IPO registration
SBFM similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this Registration Statement of Sunshine Biopharma Inc. on Form S-1/A, of our report dated March 31, 2023, on the financial statements of Sunshine Biopharma Inc. for the years ended December 31, 2022 and 2021.
In addition, we consent to the reference to us under the heading “Experts” in the Registration Statement.
/s/ B.F. Borger CPA PC
Certified Public Accountants
Denver, Colorado
February 9, 2024